does semaglutide cause vision loss Understanding and Its Impact on New study links Ozempic to

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

The agency stated that the companies promoted compounded versions of GLP-1 medications in ways that implied sameness with FDA approved drugs and obscured the source of the products, including through branding practices that suggested the telehealth firms themselves were the compounders

J Immunol 193(8):40024009

Wegovy is FDA-approved for weight loss and is available in both injection and pill form, while Ozempic is injection-only and approved for type 2 diabetes (not weight loss)

Adding digestive enzymes is unlikely to address the underlying cause of these symptoms and there is no robust evidence demonstrating benefit in this specific context